142 related articles for article (PubMed ID: 33331738)
21. [The effect of anti-VEGF therapy on the expression levels of TGF-β and related microRNAs in the vitreous of patients with proliferative diabetic retinopathy].
Guo J; Liu ZH; Pan M; An GQ; Du LP; Zhou PY; Jin XM
Zhonghua Yan Ke Za Zhi; 2021 Dec; 57(12):922-929. PubMed ID: 34865451
[No Abstract] [Full Text] [Related]
22. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'.
Prabu P; Rome S; Sathishkumar C; Gastebois C; Meugnier E; Mohan V; Balasubramanyam M
Diabetes Metab; 2019 Jun; 45(3):276-285. PubMed ID: 30165157
[TBL] [Abstract][Full Text] [Related]
23. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
Elkholy RA; Younis RL; Allam AA; Hagag RY; Abdel Ghafar MT
J Investig Med; 2021 Aug; 69(6):1189-1195. PubMed ID: 33863755
[TBL] [Abstract][Full Text] [Related]
25. [Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy].
Bondar' IA; Klimontov VV; Nadeev AP
Ter Arkh; 2008; 80(1):52-6. PubMed ID: 18326229
[TBL] [Abstract][Full Text] [Related]
26. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.
Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y
Bioengineered; 2022 Jan; 13(1):634-644. PubMed ID: 34898373
[TBL] [Abstract][Full Text] [Related]
28. Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients.
Peng H; Zhong M; Zhao W; Wang C; Zhang J; Liu X; Li Y; Paudel SD; Wang Q; Lou T
PLoS One; 2013; 8(12):e82607. PubMed ID: 24349318
[TBL] [Abstract][Full Text] [Related]
29. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
30. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
31. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy.
Torus B; Korkmaz H; Ozturk KH; Şirin FB; Argun M; Şevik S; Tök L
Minerva Endocrinol (Torino); 2023 Mar; 48(1):42-50. PubMed ID: 33213115
[TBL] [Abstract][Full Text] [Related]
33. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.
Yu H; Wang H; Su X; Cao A; Yao X; Wang Y; Zhu B; Wang H; Fang J
BMC Nephrol; 2022 Jan; 23(1):41. PubMed ID: 35062888
[TBL] [Abstract][Full Text] [Related]
34. Association of serum pentraxin 3 concentrations with diabetic nephropathy.
Wang R; Zhang J; Hu W
J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
37. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
[TBL] [Abstract][Full Text] [Related]
38. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
39. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous Assessment of MicroRNAs 126 and 192 in Diabetic Nephropathy Patients and the Relation of these MicroRNAs with Urinary Albumin.
Tayel SI; Saleh AA; El-Hefnawy SM; Elzorkany KM; Elgarawany GE; Noreldin RI
Curr Mol Med; 2020; 20(5):361-371. PubMed ID: 31629394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
